Lei Mei G, Tan Xiaoyu, Qureshi Nilofer, Morrison David C
Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Slot 511, 4301 W. Markham St., Little Rock, AR 72205, USA.
Infect Immun. 2005 Dec;73(12):8136-43. doi: 10.1128/IAI.73.12.8136-8143.2005.
Previously, we reported that expression of caveolin-1 in elicited peritoneal mouse macrophages was up-regulated by remarkably low (1.0-pg/ml) concentrations of Escherichia coli O111 lipopolysaccharide (LPS). Here we report that increases in caveolin-1 expression are manifested by different types of LPS, LPS-mimetic taxol, and heat-killed E. coli and to a much lesser extent by zymosan, polysaccharide-peptidoglycan, and heat-killed Staphylococcus aureus. Rhodobacter sphaeroides lipid A (RsDPLA) could not induce caveolin-1 expression in macrophages. Interestingly, polymyxin B (5 microg/ml) and RsDPLA show only a limited capacity to inhibit LPS-induced caveolin-1 expression. These findings suggest that expression of caveolin-1 in response to LPS may only partially be dependent upon lipid A. Recombinant tumor necrosis factor alpha marginally induces caveolin-1, suggesting that the ability of LPS to regulate caveolin-1 is not mediated primarily through an autocrine/paracrine mechanism involving this cytokine. Under conditions in which cellular levels of caveolin-1 are profoundly induced, no significant changes in TLR4 expression are observed. Of interest, caveolin-1 appears to localize to two cellular compartments, one associated with lipid rafts and a second associated with TLR4. Gamma interferon treatment inhibits the induction of caveolin-1 by LPS in macrophages. Inhibition of the p38 kinase-dependent pathway, but not the extracellular signal-regulated kinase pathway, effectively reduced the ability of LPS to mediate caveolin-1 up-regulation. Lactacystin, a potent inhibitor of the proteasome pathway, significantly modulates LPS-independent caveolin-1 expression, and lactacystin inhibits LPS-triggered caveolin-1 responses. These studies suggest that caveolin-1 up-regulation in response to LPS is likely to be proteasome dependent and triggered through the p38 kinase pathway.
此前,我们报道过,极低浓度(1.0 pg/ml)的大肠杆菌O111脂多糖(LPS)可上调诱导性腹膜小鼠巨噬细胞中小窝蛋白-1的表达。在此我们报道,不同类型的LPS、LPS模拟物紫杉醇和热灭活大肠杆菌均可使小窝蛋白-1表达增加,而酵母聚糖、多糖肽聚糖和热灭活金黄色葡萄球菌的作用则小得多。球形红杆菌脂多糖(RsDPLA)不能诱导巨噬细胞中表达小窝蛋白-1。有趣的是,多黏菌素B(5 μg/ml)和RsDPLA仅具有有限的抑制LPS诱导小窝蛋白-1表达的能力。这些发现表明,LPS诱导的小窝蛋白-1表达可能仅部分依赖于脂多糖。重组肿瘤坏死因子α对小窝蛋白-1的诱导作用微弱,这表明LPS调节小窝蛋白-1的能力并非主要通过涉及该细胞因子的自分泌/旁分泌机制介导。在小窝蛋白-1细胞水平被显著诱导的条件下,未观察到TLR4表达有明显变化。有意思的是,小窝蛋白-1似乎定位于两个细胞区室,一个与脂筏相关,另一个与TLR4相关。γ干扰素处理可抑制LPS对巨噬细胞中小窝蛋白-1的诱导作用。抑制p38激酶依赖性途径而非细胞外信号调节激酶途径,可有效降低LPS介导小窝蛋白-1上调的能力。蛋白酶体途径的强效抑制剂乳胞素可显著调节非LPS依赖性小窝蛋白-1表达,且乳胞素可抑制LPS触发的小窝蛋白-1反应。这些研究表明,LPS诱导的小窝蛋白-1上调可能依赖于蛋白酶体,并通过p38激酶途径触发。